GSK-104690

Study Sponsor: GSK

Study Title

Blinded, randomized study to evaluate the immunogenicity and safety of GlaxoSmithKline Biologicals’ measles-mumps-rubella-varicella candidate vaccine given to healthy children during the second year of life

Medicine or Vaccine (generic name)

Combined Measles, Mumps, Rubella, Varicella Vaccine

Sponsor Identification Number

104690

Trial Registry Identification Number(#'s)

NCT00127010

Medical Condition

Measles; Mumps; Rubella; Varicella

Phase

Phase 3

Link to GSK Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=103388

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT00127010

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

This is a follow-up study to 103388. The results of this study 104690 are summarised with study 103388 on the GSK Study Register. An annotated case report form is not available for this study. A blank case report form will be provided.

Date Added to this Site

September 2015